Rabbani, Syed Arman

Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases

Neupane, Y. R., Mahtab, A., Siddiqui, L., Singh, A., Gautam, N., Rabbani, S. A., Goel, H., & Talegaonkar, S. (2020) · Current Pharmaceutical Design

Nanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug Delivery

Cited by 21

Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole

Satyam, S. M., El-Tanani, M., Patni, M. A., Rehman, A., Wali, A. F., Rangraze, I. R., Babiker, R., Rabbani, S. A., El-Tanani, Y., & Rizzo, M. (2025) · Antibiotics

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 9